hydromorphone has been researched along with Endocarditis, Bacterial in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 2 (66.67) | 2.80 |
| Authors | Studies |
|---|---|
| Bayoumi, AM; Bouck, Z; Harris, C; Hezam, A; Lai, Y; Nincic, V; Parker, A; Straus, SE; Tricco, AC; Yazdi, F | 1 |
| Coleman, CE; Hallam, B; Kasper, KJ; Koivu, SL; Manoharan, I; McCormick, JK; Silverman, MS; Weir, MA | 1 |
| Bassareo, PP | 1 |
1 review(s) available for hydromorphone and Endocarditis, Bacterial
| Article | Year |
|---|---|
Controlled-release hydromorphone and risk of infection in adults: a systematic review.
Topics: Adult; Case-Control Studies; Delayed-Action Preparations; Endocarditis; Endocarditis, Bacterial; Hepacivirus; Hepatitis C; HIV Infections; Humans; Hydromorphone; Retrospective Studies; Substance Abuse, Intravenous | 2023 |
2 other study(ies) available for hydromorphone and Endocarditis, Bacterial
| Article | Year |
|---|---|
A controlled-release oral opioid supports S. aureus survival in injection drug preparation equipment and may increase bacteremia and endocarditis risk.
Topics: Administration, Oral; Bacteremia; Delayed-Action Preparations; Drug Compounding; Endocarditis, Bacterial; Equipment Contamination; Hydromorphone; Injections; Microbial Viability; Risk; Staphylococcus aureus | 2019 |
Hydromorphone and risk of infective endocarditis.
Topics: Cohort Studies; Endocarditis; Endocarditis, Bacterial; Humans; Hydromorphone; Retrospective Studies | 2020 |